Interdisciplinary Research

These papers were selected from multiple disciplines from the Faculty of 1000, a Web-based literature awareness tool http://www.facultyof1000.com.D.D. Sarbassov et al., "Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton," Curr Biol, 14:1296–302, July 27, 2004.The authors describe a novel molecular mechanism whereby downstream signaling in the mammalian target of the rapamycin (mTOR) pathway may proceed in

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

These papers were selected from multiple disciplines from the Faculty of 1000, a Web-based literature awareness tool http://www.facultyof1000.com.

D.D. Sarbassov et al., "Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton," Curr Biol, 14:1296–302, July 27, 2004.

The authors describe a novel molecular mechanism whereby downstream signaling in the mammalian target of the rapamycin (mTOR) pathway may proceed in a rapamycin-insensitive manner. This may help explain several recent reports of rapamycin-resistant effects resulting from cellular mTOR activation and also has implications for the design of drugs targeting the mTOR pathway.

- Peter Taylor

University of Dundee, UK

N. Ramachandran et al., "Self-assembling protein microarrays," Science, 305:86–90, July 2, 2004.

Protein microarrays were generated by printing cDNAs onto glass slides, translating target proteins with mammalian reticulocyte lysate, and using epitope tags fused to the proteins to immobilize them in situ.

- Benoit Coulombe

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies